| Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer MCA Wouters, BH Nelson Clinical Cancer Research 24 (24), 6125-6135, 2018 | 366 | 2018 |
| Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and … E van Schooneveld, MCA Wouters, I Van der Auwera, DJ Peeters, ... Breast cancer research 14, 1-16, 2012 | 222 | 2012 |
| A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer EM Dijkgraaf, S Santegoets, AKL Reyners, R Goedemans, MCA Wouters, ... Annals of Oncology 26 (10), 2141-2149, 2015 | 159 | 2015 |
| A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer HH Workel, JM Lubbers, R Arnold, TM Prins, P van der Vlies, K de Lange, ... Cancer immunology research 7 (5), 784-796, 2019 | 154 | 2019 |
| CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma HH Workel, FL Komdeur, MCA Wouters, A Plat, HG Klip, FA Eggink, ... European journal of cancer 60, 1-11, 2016 | 142 | 2016 |
| Treatment regimen, surgical outcome, and T-cell differentiation influence prognostic benefit of tumor-infiltrating lymphocytes in high-grade serous ovarian cancer MCA Wouters, FL Komdeur, HH Workel, HG Klip, A Plat, NM Kooi, ... Clinical Cancer Research 22 (3), 714-724, 2016 | 85 | 2016 |
| CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy FL Komdeur, MCA Wouters, HH Workel, AM Tijans, ALJ Terwindt, ... Oncotarget 7 (46), 75130, 2016 | 81 | 2016 |
| Homologous recombination DNA repair pathway disruption and retinoblastoma protein loss are associated with exceptional survival in high-grade serous ovarian cancer DW Garsed, K Alsop, S Fereday, C Emmanuel, CJ Kennedy, ... Clinical Cancer Research 24 (3), 569-580, 2018 | 75 | 2018 |
| Single-cell profiles and prognostic impact of tumor-infiltrating lymphocytes coexpressing CD39, CD103, and PD-1 in ovarian cancer CM Laumont, MCA Wouters, J Smazynski, NS Gierc, EA Chavez, ... Clinical Cancer Research 27 (14), 4089-4100, 2021 | 58 | 2021 |
| Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer MCA Wouters, EM Dijkgraaf, ML Kuijjer, ES Jordanova, H Hollema, ... Oncoimmunology 3 (12), e962397, 2014 | 39 | 2014 |
| CD20+ T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancer M de Bruyn, VR Wiersma, MCA Wouters, DF Samplonius, HG Klip, ... Oncoimmunology 4 (4), e999536, 2015 | 34 | 2015 |
| C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity VR Wiersma, M de Bruyn, C Shi, MJM Gooden, MCA Wouters, ... MAbs 7 (2), 321-330, 2015 | 30 | 2015 |
| Cancer immunotherapy principles and practice LH Butterfield, HL Kaufman, FM Marincola Springer Publishing Company, 2021 | 28 | 2021 |
| The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers J Smazynski, PT Hamilton, S Thornton, K Milne, MCA Wouters, JR Webb, ... Gynecologic Oncology 158 (1), 167-177, 2020 | 26 | 2020 |
| Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome KL Brunekreeft, ST Paijens, MCA Wouters, FL Komdeur, FA Eggink, ... Oncoimmunology 9 (1), 1760705, 2020 | 12 | 2020 |
| Co-expression patterns of chimeric antigen receptor (CAR)-T cell target antigens in primary and recurrent ovarian cancer AC Banville, MCA Wouters, AL Oberg, KM Goergen, MJ Maurer, K Milne, ... Gynecologic oncology 160 (2), 520-529, 2021 | 11 | 2021 |
| Size matters: survival benefit conferred by intratumoral T cells is dependent on surgical outcome, treatment sequence and T cell differentiation MCA Wouters, FL Komdeur, M de Bruyn, HW Nijman Oncoimmunology 5 (5), e1122863, 2016 | 8 | 2016 |
| Nadia Traficante, for the Australian Ovarian Cancer Study Group: Homologous recombination DNA repair pathway disruption and retinoblastoma protein loss are associated with … DW Garsed, K Alsop, S Fereday, C Emmanuel, CJ Kennedy, ... Clin Cancer Res 24, 569-580, 2018 | 6 | 2018 |
| What Is Flow Cytometry? M Wouters | 2 | 1980 |
| Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19 A Isman, A Nyquist, B Strecker, G Harinath, V Lee, X Zhang, S Zalzala Brain, Behavior, & Immunity-Health 36, 100733, 2024 | 1 | 2024 |
NijmanDirección de correo verificada de umcg.nl
